e-Therapeutics plc Notice of AGM (8523J)
April 04 2018 - 11:13AM
UK Regulatory
TIDMETX
RNS Number : 8523J
e-Therapeutics plc
04 April 2018
e-therapeutics plc
Notice of Annual General Meeting and Annual Report
4 April 2018: e-therapeutics plc (AIM: ETX, "e-therapeutics" or
the "Company"), the drug discovery company, announces that its
Annual Report and accounts for the year ended 31 January 2018,
which includes the notice convening the Company's 2018 Annual
General Meeting ("AGM"), can be downloaded from the Company's
website at
https://www.etherapeutics.co.uk/investors/reports-results/ and will
be posted to Shareholders on 6 April 2018.
The 2018 AGM will take place at 11:00 am on 31 May 2018 at the
offices of Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M
7SH.
-Ends-
For more information, please contact:
e-therapeutics plc Tel: +44 (0)1993
Iain Ross, Chairman 883 125
Ray Barlow, Chief Executive www.etherapeutics.co.uk
Officer
Steve Medlicott, Finance
Director
Numis Securities Limited Tel: +44 (0) 207
Michael Meade / Freddie Barnfield 260 1000
(Nominated Adviser) www.numis.com
James Black (Corporate Broking)
Instinctif Partners Tel: +44 (0) 207
Melanie Toyne Sewell / Alex 457 2020
Shaw Email: e-therapeutics@instinctif.com
About e-therapeutics plc
e-therapeutics is an Oxford-based company with a unique and
powerful computer-based drug discovery platform and specialised
approach to network biology.
Its novel methodology and discovery engine allow the Company to
discover new and better drugs in a more efficient and effective
way.
For more information about the Company, please visit
www.etherapeutics.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOAUSAVRWUASRAR
(END) Dow Jones Newswires
April 04, 2018 11:13 ET (15:13 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024